Anti-IL 23 biologics for the treatment of plaque psoriasis
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2132143
Abstract: ABSTRACT Introduction Psoriasis is a chronic inflammatory disease that can drastically affect a patient’s quality-of-life and is associated with multiple comorbid conditions. The most common form of psoriasis is plaque psoriasis, commonly presenting as sharply… read more here.
Keywords: therapy; moderate severe; anti biologics; plaque psoriasis ... See more keywords
Characteristics of anti-IL-17/23 biologics-induced interstitial pneumonia in patients with psoriasis
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0245284
Abstract: Objectives Anti-IL-17/23 biologics are increasingly used to treat psoriasis. We aimed to elucidate characteristics of drug-induced interstitial pneumonia (DIIP) caused by anti-IL-17/23 biologics. Methods We retrospectively analyzed the clinical data of psoriasis patients treated with… read more here.
Keywords: induced interstitial; diip; psoriasis; interstitial pneumonia ... See more keywords
Heterogeneous Response of Airway Eosinophilia to Anti-IL-5 Biologics in Severe Asthma Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12010070
Abstract: Many questions concerning responders (R) and nonresponders (NR) in severe eosinophilic asthma (SEA) after blocking the IL-5 (interleukin 5) pathway are still not clear, especially regarding the early parameters of response to biologics in personalized… read more here.
Keywords: response airway; eosinophilia anti; airway eosinophilia; heterogeneous response ... See more keywords